-       Report 
- October 2024
-  89 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- December 2024
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- December 2024
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- December 2024
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
           -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
             The Clinical Trial Imaging market is a subset of the Medical Imaging industry. It involves the use of imaging technologies such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and positron emission tomography (PET) to assess the safety and efficacy of medical treatments and interventions. Clinical trial imaging is used to monitor the progress of a patient's condition, detect changes in the body, and assess the effectiveness of treatments. It is also used to assess    the safety of new drugs and medical devices. Clinical trial imaging is an important part of the drug development process, as it helps to ensure that treatments are safe and effective.
Some companies in the Clinical Trial Imaging market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Toshiba Medical Systems, Hitachi Medical Systems, and Shimadzu Corporation. Show Less   Read more